Silly science and frivolous funding: The history of statins

Akira Endo
Nature Medicine (2008)
doi:10.1038/nm1008-1050
Government funding of scientific research is often a targeted due to publicized ‘weird science.’ Yet, ‘weird scientists’ are behind several of the most important medical breakthroughs of our time! One such example include statins, a group of drugs commonly prescribed to treat high cholesterol. Over half of all American men and more than 2 in 5 American women over the age 65 take statins (National Center for Health Statistics, Health, United States, 2012).

Their unlikely origin: Fungi.

Dr. Akira Endo discovered the first statins in a screen searching for inhibitors of cholesterolgenesis from chemical compounds derived from Penicillium citrinum in the 1970s.  Three of the 6000 compounds tested reduced cholesterol synthesis in a rat liver enzyme model. (Talk about successful drug discovery!)  Today, statins remain the subject of ongoing research in the prevention of dementia, reduction of inflammation, and treatment of cancer and stroke.

An extra--Statins and diabetes risk: Risk of incident diabetes among patients treated with statins: population based study. 

An NPR report detailing a recent 'weird science' controversy (worth a listen!):  'Shrimp On A Treadmill': The Politics Of 'Silly' Studies

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.